We take your privacy very seriously, please consent to the use of all cookies when visiting our website. for more information on the processing of personal data, please refer to the Privacy Policy.

EN
Make an Appointment

Foshan Investment Promotion Bureau, together with Foshan Korea Chamber of Commerce and Korean Biotechnology Enterprises, Visits HeYou

  • News
  • 2024-03-19

   On the afternoon of March 11, a delegation led by Chen Xinwen, Secretary of the Party Leadership Group and Director of the Foshan Investment Promotion Bureau, along with Bae Bo-kyun, President of the Foshan Korea Chamber of Commerce, Lee Hyung-seung, Chairman of TS BIO Co., Ltd., and Jeong Ho-jin, Chairman of Guangdong Zhenhong Biotechnology Co., Ltd., visited HeYou International Hospital Group. Liu Xiaofang, Deputy Director of the Management Committee and President of HeYou International Hospital Group, and Lu Jiade, Vice President, extended a warm welcome to the visiting delegation. Both parties engaged in in-depth exchanges and discussions on cooperation opportunities in the healthcare and health industry.


During the symposium, TS BIO Co., Ltd. presented its research and development achievements and market layout in the fields of biotechnology and healthcare. TS BIO Co., Ltd. is a biotechnology company based in South Korea, primarily focused on the cultivation technology of stem cells and NK cells, committed to advancing the bio-industry through technological innovation.


HeYou International Hospital Group also provided a detailed overview of its development progress and future strategy. HeYou Hospital will officially commence operations at the end of June 2024, providing high-quality medical services to the public. Concurrently, it is committed to building a research-oriented hospital, actively seeking close and pragmatic collaborations with renowned medical schools, hospitals, and research institutions both domestically and internationally, to drive innovation and development in the healthcare field.


Chen Xinwen, Secretary of the Party Leadership Group and Director of the Foshan Investment Promotion Bureau, expressed his hope that this exchange would enhance the complementary advantages of biotechnology research between China and South Korea, promote cooperation, and provide an opportunity for both sides to work together to advance the high-quality development of the healthcare industry.


This visit and exchange not only strengthened the communication and connection between Korean biotechnology enterprises and HeYou International Hospital Group but also provided broad space and opportunities for in-depth cooperation between the two parties in the healthcare field.